Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance.
BACKGROUNDScipio is, open-label trial’s first-in-human, section 1, randomized of autologous c-kit (+) cardiac stem cells (CSC) in patients with coronary heart failure of ischemic etiology present process coronary artery bypass grafting (CABG). In this examine, we report the surgical aspects and interim cardiac magnetic resonance (CMR) outcomes. RESULTSA complete of 33 patients (20 CSC-treated and …